Benefits of sacubitril/valsartan administration and physical training in cardiac rehabilitation: current trends and bibliometric analysis of the years 2015-2024
-
Published:2024-06-21
Issue:Vol.15, no. 2
Volume:15
Page:683-683
-
ISSN:2734-8458
-
Container-title:Balneo and PRM Research Journal
-
language:en
-
Short-container-title:
Author:
Iovanovici Diana Carina1, Dogaru Bombonica Gabriela1, Nistor – Cseppento Carmen Delia1, Purza Anamaria Lavinia2, Aur Cristina3, Mocuta Diana3, Behl Tapan4, Bungau Simona Gabriela1
Affiliation:
1. Doctoral School of Biomedical Sciences, University of Oradea 2. Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea 3. Department of Surgical Disciplines Faculty of Medicine and Pharmacy, University of Oradea 4. 6 School of Health Sciences & Technology, University of Petroleum and Energy Studies
Abstract
Introduction. Heart failure, with its economic and social burden and increasing incidence in the general population, is a global problem. Since 2015, a new class of drugs with angiotensin and neprilysin re-ceptor inhibitory action, namely the combination of sacubitril and valsartan (S/V), has been introduced in the treatment of HF. The study aimed to perform a bibliometric analysis of the available knowledge and assess research trends through quantitative analysis of the literature related to the use of S/V and physical training in HF. Methods. In the study, we used the Web of Science database, period 2015-January 2024. The data obtained was processed with Vos viewer and Microsoft Excel. The results obtained and their interpretation provided an overview of the most relevant and prolific journals, countries, authors, and organizations. Conclusion. After marketing approval, the publication trend was upward until 2023, when the number of publica-tions decreased significantly. Our study shows that although the number of publications de-creased, updates of treatment guidelines were published, and a significant number of articles supporting the benefits of S/V treatment in chronic HF (with reduced or preserved ejection frac-tion) but also in acute forms were published. Although the number of articles on cardiac rehabilitation is low, this is highlighted in treatment guidelines and studies have emerged assessing the reasons why patients do not follow a cardiac rehabilitation programme. Cardiac rehabilitation is important for its physiological benefits: improving VO2max, myocardial blood flow and endothelial function. Health policies should be put in place to raise awareness of the importance of cardiac rehabilitation, including distances to a rehabilitation centre.
Keywords: sacubitril/valsartan; heart failure; cardiac rehabilitation; bibliometric analysis
Publisher
Romanian Association of Balneology
Reference140 articles.
1. M. D. Flather et al., "Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group," (in eng), Lancet, vol. 355, no. 9215, pp. 1575-81, May 06 2000, doi: 10.1016/s0140-6736(00)02212-1. 2. [2] M. Fiuzat et al., "Endpoints in Heart Failure Drug Development: History and Future," (in eng), JACC Heart Fail, vol. 8, no. 6, pp. 429-440, Jun 2020, doi: 10.1016/j.jchf.2019.12.011. 3. [3] D. C. Iovanovici et al., "Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure," (in eng), Int J Mol Sci, vol. 23, no. 19, Sep 26 2022, doi: 10.3390/ijms231911336. 4. [4] T. J. Hwang, J. C. Lauffenburger, J. M. Franklin, and A. S. Kesselheim, "Temporal Trends and Factors Associated With Cardiovascular Drug Development, 1990 to 2012," (in eng), JACC Basic Transl Sci, vol. 1, no. 5, pp. 301-308, Aug 2016, doi: 10.1016/j.jacbts.2016.03.012. 5. [5] M. Fiuzat, N. Stockbridge, and R. M. Califf, "Resourcing Drug Development Commensurate With its Public Health Importance: The Road Ahead," (in eng), JACC Basic Transl Sci, vol. 1, no. 5, pp. 309-312, Aug 2016, doi: 10.1016/j.jacbts.2016.07.003.
|
|